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Abstract
Background: The mismatch repair (MMR) pathway plays an important role in the maintenance of the genome
integrity, meiotic recombination and gametogenesis. This study investigated whether genetic variations in MMR
genes are associated with an increased risk of sperm DNA damage and male infertility.
Methods: We selected and genotyped 21 tagging single nucleotide polymorphisms (SNPs) in five MMR genes
(MLH1, MLH3, PMS2, MSH4 and MSH5) using the SNPstream 12-plex platform in a case-control study of 1,292
idiopathic infertility patients and 480 fertile controls in a Chinese population. Sperm DNA damage levels were
detected with the Tdt-mediated dUTP nick end labelling (TUNEL) assay in 450 cases. Fluorescence resonance
energy transfer (FRET) and co-immunoprecipitation techniques were employed to determine the effects of
functional variants.
Results: One intronic SNP in MLH1 (rs4647269) and two non-synonymous SNPs in PMS2 (rs1059060, Ser775Asn)
and MSH5 (rs2075789, Pro29Ser) seem to be risk factors for the development of azoospermia or oligozoospermia.
Meanwhile, we also identified a possible contribution of PMS2 rs1059060 to the risk of male infertility with normal
sperm count. Among patients with normal sperm count, MLH1 rs4647269 and PMS2 rs1059060 were associated
with increased sperm DNA damage. Functional analysis revealed that the PMS2 rs1059060 can affect the
interactions between MLH1 and PMS2.
Conclusions: Our results provide evidence supporting the involvement of genetic polymorphisms in MMR genes
in the aetiology of male infertility.
Background
Infertility remains a major clinical problem that occurs
in 10 to 15% of couples worldwide [1], and male factor
infertility accounts for 40 to 50% of all infertility cases
[2]. Although several causes have been identified for
impaired male fertility [3], the aetiology remains
u n k n o w ni nn e a r l yh a l fo fa l lcases. Currently, a large
amount of attention is being paid to the potential effects
of sperm DNA damage on male infertility [4]. DNA
damage in the male germ line appears as a risk factor
for adverse clinical outcomes, including poor semen
quality, low fertilization rates, impaired pre-implantation
development, miscarriage and an increased risk of mor-
bidity in the offspring [5-7].
Although the clinical significance of testing sperm
DNA integrity has been clearly emphasized, the origin
of DNA damage in spermatozoa is poorly understood.
One mechanism is that deficits in the DNA repair sys-
tem during spermatogenesis can have negative effects
on the integrity of sperm DNA [8,9]. Our previous data
have provided strong evidence that some genetic poly-
morphisms in genes involved in DNA repair were asso-
ciated with the development of sperm DNA damage and
male infertility [10-13].
Among all DNA repair mechanisms, DNA mismatch
repair (MMR) plays a critical role in the maintenance of
genetic integrity and malfunctions can lead to various
cancers in mammals [14-16]. Studies of gene knockout
mice indicate that several members of the MMR family
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and are involved in gametogenesis [17,18]. Three MutL
homologues (MLH1, MLH3 and PMS2) and two MutS
homologues (MSH4 and MSH5) are involved in this
process.
Based on their important physiological functions, these
five MMR genes are good candidate genes for explaining
male infertility. Recently, analysis of polymorphic mar-
kers in candidate genes helped us to understand the
etiology and the susceptibility of male infertility [19-21].
The purpose of this work is three-fold: (1) to examine
whether MMR gene polymorphisms are associated with
increased risk of azoospermia or oligozoospermia, (2) to
ascertain whether genetic variants in MMR genes result
in sperm DNA damage and, thereby, increase male
infertility, and (3) to investigate the biological activity of
the significant functional variants.
Methods
Subjects and sample collection
The study was approved by the Ethics Review Board of
the Nanjing Medical University. All the studies involving
human subjects were conducted in full compliance with
government policies and the Declaration of Helsinki. A
total of 1,657 infertile patients, diagnosed with unex-
plained male factor infertility, were drawn from the
Centre of Clinical Reproductive Medicine between April
2005 and March 2009 (NJMU Infertile Study). All parti-
cipants completed an informed consent and a question-
naire, including detailed information, such as age,
cigarette smoking, alcohol drinking, tea and vitamin
consumption, and abstinence time. All patients under-
went at least two semen analyses, and those with a his-
tory of orchitis, obstruction of the vas deferens,
chromosomal abnormalities, or micro-deletions of the
azoospermia factor region on the Y chromosome were
excluded [22]. In the final analysis, 1,292 idiopathic
infertility patients aged 24 to 42 years old were included,
and were divided into three subgroups: 268 infertility
patients with non-obstructive azoospermia, 256 inferti-
lity patients with oligozoospermia (sperm counts < 20 ×
10
6/ml) and 768 infertility patients with normal count
(sperm counts ≥ 20 × 10
6/ml).
The control group included 480 fertile men ranging
from 25 to 40 years of age who had fathered at least
one child without assisted reproductive technologies and
had normal semen parameters. The semen analysis for
sperm concentration, motility and morphology was per-
formed following the World Health Organization cri-
teria [23].
SNP selection and genotyping
We selected the tagging SNPs by using genotype data
obtained from unrelated Han Chinese individuals from
Beijing in the HapMap project (HapMap Data Rel 24/
Phase II Nov08, on NCBI B36 assembly, dbSNP b126).
To examine the gene extensively, we searched the MMR
genes, including 2,000 bp of the flanking regions both
upstream and downstream of the gene, using the pair-
wise option of the Haploview 4.0 software (Mark Daly’s
Lab, Broad Institute of MIT and Harvard, Cambridge,
Massachusetts, USA). The tagging SNPs were selected
on the basis of pairwise linkage disequilibrium with a r
2
threshold of 0.8 and minor allele frequency ≥ 0.05 to
capture all the common SNPs. In total, 19 SNPs were
chosen in these 5 genes. In addition, a non-synonymous
SNP (rs1799977) in MLH1 and a non-synonymous SNP
(rs2075789) in MSH5 that cause missense mutations
were included.
Genotyping was performed using TaqMan 7900HT
Sequence Detection System and GenomeLab SNPstream
high-throughput 12-plex genotyping platform (Beckman
Coulter, Fullerton, CA, USA). Sequences of forward,
reverse and extension primers are listed in Additional
file 1 (Table S1). For quality control, the genotyping was
done without knowledge of case/control status of the
subjects, and a random 5% of cases and controls were
genotyped twice by different individuals, and the repro-
ducibility was 100%. To confirm the genotyping results,
selected PCR-amplified DNA samples (n = 2, for each
genotype) were examined by DNA sequencing and the
results were also consistent.
DNA fragmentation analysis
After a period of 48 to 72 h of sexual abstinence, semen
samples were collected by masturbation into wide-
mouthed sterile containers and were delivered to the
laboratory within 1 h of ejaculation. The diluted samples
were cooled gradually at 5°C for 2 h, frozen at -70°C for
Tdt-mediated dUTP nick end labelling (TUNEL) evalua-
tion. A detailed protocol of the TUNEL assay for
human sperm has been described previously [24].
TUNEL labeling was carried out using a Cell Death
Detection kit (APO-DIRECT kit; BD Biosciences Phar-
Mingen, San Diego, CA, USA) according to the manu-
facturer’s instructions. Briefly, semen samples were
thawed in a 37°C water bath and immediately diluted
with buffer (0.15 M NaCl, 0.01 M Tris, 0.001 M EDTA,
pH 7.4) to obtain a sperm concentration of 1 to 2 ×
10
6/ml. Washed sperm was resuspended in 2% parafor-
maldehyde for 30 minutes at room temperature. After
rinsing in PBS, samples were resuspended in permeabili-
zation solution (0.2% Triton X-100, 0.1% sodium citrate)
for 10 minutes on wet ice. TUNEL reagent (50 μl) was
added to each sample. For each batch, a negative control
lacking the terminal deoxynucleotidyl transferase and a
positive control treated with DNase I were included to
ensure assay specificity. After incubation for 1 h at 37°C,
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(FACSCalibur; BD Biosciences Pharmingen, San Diego,
CA, USA). Flow during the analysis was controlled at
approximately 500 spermatozoa/sec, and 10,000 cells
were analyzed for each sample. The percentage of FITC-
positive cells (FL1 channel) was calculated as the per-
centage of cells with a fluorescence intensity exceeding
the threshold obtained with the negative control.
Plasmid construction
To evaluate the potential effects of PMS2 rs1059060
(Ser775Asn) polymorphisms on the interaction between
MLH1 and PMS2, fluorescence resonance energy trans-
fer (FRET) technology and immunoprecipitation were
performed. The cDNA encoding MLH1 or PMS2 was
generated by PCR from a human testis cDNA library.
For the FRET assay, the primers used for amplifying
PMS2 (amino acids 655-856) were 5’-CGTTAAGCTTG-
GAGAAAATCAAGCAGCCGAAG-3’/5’-ATACG-
GATCC CAGGTTGGCGATGTGTCTCAT -3’,
including HindIII and BamHI restriction sites (under-
lined sequences). Point mutations for PMS2 were per-
formed using QuikChange Site-Directed Mutagenesis
Kit (Stratagene, La. Jolla, CA, USA). The amplified frag-
ment of PMS2 and its genetic variants were cloned into
the pEYFP-C1 vector (Clonetech, Palo Alto, CA, USA).
Similarly, the cDNA sequence encoding MLH1 (amino
acids 506-756) was amplified by PCR using the following
primers: 5’-CGTTGAATTCGTGTTTTGAGTCTCCAG-
GAAGAAA-3’/5’-ATACGGATCCACACCTCTCAAA-
GACTTTGTAT-3’, which contain EcoRI and BamHI
restriction sites (underlined sequences). This amplified
fragment was ligated into pECYP-C1 vector (Clonetech,
USA). For immunoprecipitation, the cloning of the full-
length PMS2 and MLH1 cDNA constructs into
pcDNA3.1 (Invitrogen, Carlsbad, CA, USA), between
NheI and BamHI, has already been described [25]. The
integrity of the inserts was confirmed by sequence
analysis.
Cell culture and transfection
MutLa-deficient HEK293T cells were cultured in
DMEM: F12 (1:1) (Gibco, Carlsbad, CA, USA), supple-
mented with 10% foetal bovine serum and 0.1% strepto-
mycin/penicillin (Gibco, USA) in a humidified
atmosphere with 5% CO2 at 37°C. Cells were seeded
onto 30 mm dishes with poly-L-lysine-coated glass cov-
erslips and co-transfected with YFP recombinant plas-
mid (YFP-PMS2 or variants of YFP-PMS2) and CFP
recombinant plasmid (CFP-MLH1) using Lipofectamine
2000 (Invitrogen) until the cells were at 50 to 60% con-
fluence, according to the manufacturer’sp r o t o c o l s .T h e
transfection efficiency was compared by Western blot-
ting at 72 hours after transfection using anti-PMS2
(A16-4) (1:100; BD Biosciences), anti-MLH1 (G168-728)
(1:100; BD Biosciences), and anti-b actin (1:5000; Santa
Cruz Biotechnology, CA, USA) antibodies.
Image analysis and calculation of fluorescence resonance
energy transfer ratios
We used a Zeiss LSM710 confocal microscope (Carl
Zeiss, Jena, Germany) operating with a 40 mW argon
laser. Filter-cube specifications for the fluorescent chan-
nels were as follows for excitation and emission, respec-
tively: enhanced cyan fluorescent protein (ECFP), 430 ±
25 and 470 ± 30 nm; enhanced yellow fluorescent pro-
tein (EYFP), 500 ± 20 and 535 ± 30 nm; and fluores-
cence resonance energy transfer (FRET), 430 ± 25 and
535 ± 30 nm.
Image analysis involved three basic operations: sub-
traction of background autofluorescence and blurred
light, quantification of fluorescence intensity, and calcu-
lation of a corrected FRET (FRETc) by the following
equation:
FRETc = (IDA -aI AA -dI DD)/IAA,w h e r eIDA is the
fluorescence intensity from the FRET filter set and IDD
and IAA are the fluorescent intensities from ECFP (the
donor) and EYFP (the acceptor), respectively. The cross-
talk coefficients a and d were considered constant. The
corrected FRET ratio was defined as FRETc/IDD.
Co-Immunoprecipitation and Western blotting
Proteins were extracted from co-transfected HEK293T
cells by the M-PER
® Mammalian Protein Extraction
Reagent (Pierce Bio, Thermo, Rockford, IL, USA)
according to the manufacturer’s instruction. Approxi-
mately 200 μg total cell protein was transferred to a 1.5
ml microcentrifuge tube, and 20 μlo fP r o t e i nA / G
PLUS-Agarose (Santa Cruz Biotechnology, CA, USA)
was added to the supernatant and the mixture was incu-
bated at 4°C on a rocker platform for one hour. After
this incubation, 2 μg anti-MLH1 N-20 (Santa Cruz Bio-
technology, CA, USA) was added and incubated with
shaking at 4°C overnight. The immunoprecipitates were
collected by centrifugation at 1,000 × g for 5 minutes at
4°C, washed 4 times with lysis buffer and then the preci-
pitates were collected for the Western blotting detection
with the anti-PMS2 (A16-4) (1:100; BD Biosciences)
antibody. Proteins were then detected with a Phototope-
HRP Western Blot Detection kit (Cell Signalling Tech-
nology, Inc., Beverly, MA, USA).
Statistical analyses
Differences in select demographic variables, as well as
smoking and alcohol status, between the cases and the
controls, were evaluated using the c
2 test. The Student’s
t test was used to evaluate continuous variables, includ-
ing age and pack-years of cigarette smoking. The
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ness-of-fit c
2 test. We used unconditional multivariate
logistic regression analysis to examine associations
between genetic polymorphisms and male infertility risk
by estimating ORs and 95% confidence intervals (95%
CI). To reduce the potential for spurious findings due to
multiple testing, we applied the False Discovery Rate
(FDR) method to the P-values for the differences of gen-
otype distributions among cases and controls. False Dis-
covery Rate (FDR) is a new approach to the multiple
comparisons problem. Instead of controlling the chance
of any false positives (as Bonferroni methods do), FDR
controls the expected proportion of false positives
among suprathreshold voxels [26].
Sperm DNA fragmentation was normalized by natural
logarithm (ln) transformation. Linear regression models
were used to estimate the association with ln-trans-
formed sperm fragmentation values for each SNP inde-
pendently. Models were adjusted for age, smoking
status, drinking status and abstinence time. All P-values
presented are two-sided and all analyses were carried by
the Statistical Analysis Software, version 9.1.3 (SAS
Institute, Cary, NC, USA).
Results
Subject characteristics
The final study population consisted of 1,772 Han Chinese
individuals, composed of 480 fertile controls, 268 infertility
patients with non-obstructive azoospermia, 256 infertility
patients with oligozoospermia (sperm counts < 20 × 10
6/
ml) and 768 infertility patients with normal sperm count
(sperm counts ≥ 20 × 10
6/ml). The frequency distributions
of selected characteristics of the case patients and control
subjects are presented in Table 1. No significant differ-
ences were observed between cases and controls with
regard to drinking status or age. However, there was a sig-
nificantly higher percentage of smokers among cases than
controls (P < 0.001). Among smokers, cases also reported
greater cigarette consumption than controls, as assessed
by the mean number of pack-years (P < 0.05). As expected,
semen parameters, such as sperm concentration and
sperm motility, were significantly higher in fertile controls
than infertile cases (P <0 . 0 0 1 ) .
Allelic frequencies and genotype distributions of MMR
polymorphisms
The position and minor allele frequency among Chinese of
the 21 SNPs in the HapMap database are presented in
Additional file 2 (Table S2). All SNPs were in Hardy-
Weinberg equilibrium among the controls, except for
rs3117572 (P = 0.024). Inspection of the cluster plots indi-
cated good discrimination between genotypes, suggesting
that these deviations from HWE are likely to be chance
observations. The genotype distributions among cases and
controls are presented in Table 2. Overall, the genotype
frequencies of three SNPs were significantly different
between the patients with azoospermia or oligozoospermia
and the controls (P = 0.032 for rs4647269, P =0 . 0 0 3f o r
rs1059060 and P = 0.002 for rs2075789). Moreover, the
genotype frequencies of rs1059060 were also significantly
different between the patients with normal sperm count
and the controls (P =2 . 0×1 0
-4).
Table 1 Distribution of selected characteristics between cases and fertile controls
Variables Controls
(n = 480)
Case 1
a
(n = 524)
Case 2
b
(n = 768)
N (%) N (%) P
d N (%) P
d
Age (mean ± SEM) 28.1 ± 0.16 28.3 ± 0.16 0.374 28.3 ± 0.14 0.355
Smoking stauts
Never 278 (57.9) 238 (45.4) < 0.001 363 (47.3) < 0.001
Ever 202 (42.1) 286 (54.6) 405 (52.7)
Pack-years (mean ± SEM)
c 4.3 ± 0.21 5.2 ± 0.20 0.002 4.9 ± 0.14 0.014
Drinking status
Never 425 (88.5) 447 (85.3) 0.129 667 (86.8) 0.377
Ever 55 (11.5) 77 (14.7) 101 (13.2)
Semen parameters (mean ± SEM)
Concentration (× 10
6 /ml) 102.6 ± 3.07 5.12 ± 0.38 < 0.001 73.6 ± 2.12 < 0.001
Motility (%) 65.3 ± 0.58 3.26 ± 0.27 < 0.001 37.9 ± 0.55 < 0.001
Volume (ml) 2.80 ± 0.07 2.37 ± 0.07 < 0.001 2.78 ± 0.05 0.818
Sperm DNA fragmentation (%) n. d. n. d. 19.5 ± 0.82
aCase 1: idiopathic infertile men with azoospermia or oligozoospermia.
bCase 2: idiopathic infertile men with normal sperm count.
cAmong ever smokers.
dP-values were derived from the c
2 test for categorical variables (smoking and drinking status) and t test for continuous variables (age and pack-years).
n. d.: not detected.
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nant-effect model, significantly increased risks of azoos-
permia or oligozoospermia were associated with
rs4647269 CT/TT (adjusted OR = 1.63, 95% CI: 1.10 to
2.41), rs1059060 GA/AA (adjusted OR = 1.60, 95% CI:
1.17 to 2.18) and rs2075789GA/AA (adjusted OR =
1.83, 95% CI: 1.32 to 2.55), as compared to wild-type
homozygous carriers (Table 3). Meanwhile, a signifi-
cantly increased risk of male infertility with normal
sperm count was associated with the rs1059060 GA/AA
genotypes (adjusted OR = 1.83, 95% CI: 1.37 to 2.43), as
compared to wild-type homozygotes.
Association between MMR polymorphisms and sperm
DNA fragmentation
Considering the importance of the MMR pathway in
maintenance of DNA integrity, we further evaluated the
effects of these three SNPs on sperm DNA fragmenta-
tion. In the present study, semen samples were pre-trea-
ted with cryopreservation prior to TUNEL analyses.
However, it has been demonstrated that the process of
cryopreservation can lead to an increase in oxidative
stress and percentage DNA fragmentation [27]. To
determine whether the results of the TUNEL analyses
were profoundly influenced by cryopreservation in our
study, 10 semen samples were pre-treated with or with-
out cryopreservation prior to TUNEL analyses. As
shown in Additional file 3 (Table S3), modest but sig-
nificant elevated levels of sperm DNA fragmentation
were induced by cryopreservation (P = 0.001). However,
all the semen samples undergo the same cryopreserva-
tion process, thus we believe that the effect of cryopre-
servation, if any, is unlikely to be substantial. The non-
normal distribution of sperm DNA damage levels and
sperm concentration were natural log (ln) transformed
for further association studies (skewness-kurtosis tests P
>0 . 0 5 ) .A f t e ra d j u s t m e n tf o ra g e ,s m o k i n g ,a l c o h o lu s e
and length of abstinence, we found that subjects who
carried the rs4647269 CT/TT genotypes displayed
markedly higher levels of sperm DNA fragmentation
compared with the CC homozygotes (mean ± S.D.,
11.82% ± 2.66% vs. 26.58% ± 1.97%; P <0 . 0 0 1 )( F i g u r e
1A). Moreover, a gradual increase in sperm DNA frag-
mentation was found among the three PMS2 rs1059060
subgroups (mean ± S.D., 12.30% ± 2.72%, 17.99% ±
2.27%, and 24.78% ± 1.70% for GG, GA and AA,
respectively; Ptrend < 0.001) (Figure 1B). However, no
significant difference was observed for the MSH5
rs2075789 (Figure 1C).
Effects of the PMS2 Ser775Asn polymorphism on MLH1
and PMS2 interaction
The PMS2 Ser775Asn polymorphism (rs1059060) was
potentially located within the MLH1-PMS2 interacting
domain. Therefore, we examined whether PMS2 Ser775-
Asn polymorphisms influence binding between MLH1
and PMS2. HEK293T cells were transiently co-trans-
fected with plasmids encoding the MLH1 (amino acids
506-756) and wild-type or genetic variants of PMS2
(amino acids 675-850). The schematic diagram of the
FRET assay is summarized in Additional file 4 (Figure
S1). By confocal fluorescence detection, we found that
there was a weak interaction between MLH1 and
PMS2-775Asn proteins, for little FRETc was detected in
cells co-expressing CFP-MLH1 and YFP-PMS2-775Asn
plasmid (Figure 2B). Cells co-expressing CFP-MLH1 +
YFP-PMS2-775Ser had a four-fold increase in FRETc
values (0.031 ± 0.013, n = 12; 0.008 ± 0.005, n = 12; P <
0.001) (Figure 2A). This result suggested that the PMS2
Ser775Asn polymorphism could significantly influence
the interaction between MLH1 and PMS2.
Table 2 Distribution of the genotype in selected SNPs of
MMR genes
Gene tSNP Controls
MAF
Case1
a
MAF
P
c Case2
b
MAF
P
c
MLH1
rs1799977 0.023 0.028 0.628 0.025 0.828
rs4647269 0.047 0.075 0.032 0.067 0.175
rs1540354 0.304 0.343 0.326 0.331 0.428
PMS2
rs3815383 0.332 0.332 0.923 0.342 0.816
rs2286680 0.074 0.080 0.772 0.089 0.491
rs11769380 0.410 0.419 0.816 0.379 0.736
rs1059060 0.091 0.146 0.003 0.170 2.0 ×
10
-4
rs2228006 0.063 0.054 0.520 0.056 0.582
MLH3
rs13712 0.184 0.185 0.913 0.185 0.962
rs7156586 0.222 0.217 0.832 0.406 0.527
rs175049 0.185 0.173 0.646 0.177 0.727
MSH4
rs1021462 0.309 0.336 0.592 0.317 0.842
MSH5
rs3749953 0.121 0.154 0.278 0.148 0.653
rs1150793 0.142 0.141 0.960 0.138 0.827
rs707939 0.359 0.337 0.582 0.357 0.886
rs707938 0.304 0.331 0.557 0.336 0.231
rs3115672 0.375 0.402 0.681 0.377 0.929
rs3117572 0.223 0.206 0.724 0.231 0.782
rs2299850 0.063 0.056 0.652 0.068 0.720
rs9461718 0.144 0.161 0.472 0.157 0.567
rs2075789 0.081 0.139 0.002 0.097 0.485
Abbreviations: MAF, minor allele frequency.
aCase 1: idiopathic infertile men with azoospermia or oligozoospermia.
bCase 2: idiopathic infertile men with normal sperm count.
Data in bold highlights the statistic significant results.
cFalse Discovery Rate (FDR) corrected P-value.
Data in boldface represent P < 0.05.
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the effects of PMS2 variants on the MLH1 and PMS2
interaction. Full-length MLH1 and PMS2 775Ser or
PMS2 775Asn were constructed and co-transfected into
HEK293T cells. Western blot analysis of whole cell
lysates showed satisfied transfection efficiency (Figure
3A). The co-immunoprecipitated result also suggested
that binding between MLH1 and PMS2-775Ser was
more robust compared with binding between MLH1
and the PMS2-775Asn variant (Figure 3B, lane 4 vs. 3)
Table 3 Genotype frequencies of the four SNPs in MMR genes in patients and controls and their associations with
male infertility risk
SNP ID Genotype Controls (n = 480) Case 1
a (n = 524) Case 2
b (n = 768)
N (%) N (%) OR (95% CI)
c N (%) OR (95% CI)
c
MLH1
rs4647269 CC 431 (90.5) 444 (85.5) Reference 665 (86.6) Reference
CT 45 (9.4) 72 (13.9) 1.56 (1.05 to 2.32) 94 (12.2) 1.34 (0.92 to 1.96)
TT 0 (0.0) 3 (0.6) NA 4 (0.5) NA
CT/TT 45 (9.4) 75 (14.4) 1.63 (1.10 to 2.41) 98 (12.7) 1.39 (0.93 to 2.01)
Ptrend 0.009 0.044
PMS2
rs1059060 GG 393 (82.6) 387 (74.6) Reference 534 (69.5) Reference
GA 79 (16.6) 112 (21.6) 1.43 (1.03 to 1.96) 197 (25.6) 1.82 (1.36 to 2.44)
AA 4 (0.8) 20 (3.8) 5.03 (1.70 to 14.84) 31 (4.0) 5.65 (1.98 to 16.15)
GA/AA 83 (17.4) 132 (25.4) 1.60 (1.17 to 2.18) 228 (29.6) 1.83 (1.37 to 2.43)
Ptrend 0.0003 < 0.0001
MSH5
rs2075789 GG 401 (85.7) 392 (76.4) Reference 626 (83.2) Reference
GA 58 (12.4) 99 (19.3) 1.73 (1.22 to 2.47) 106 (14.1) 1.16 (0.82 to 1.63)
AA 9 (1.9) 22 (4.2) 2.48 (1.13 to 5.46) 20 (2.6) 1.41 (0.63 to 3.12)
GA/AA 67 (14.3) 121 (23.6) 1.83 (1.32 to 2.55) 126 (19.7) 1.19 (0.86 to 1.64)
Ptrend 0.0002 0.224
aCase 1: idiopathic infertile men with azoospermia or oligozoospermia.
bCase 2: idiopathic infertile men with normal sperm count.
cAdjustment for age, smoking status and alcohol use.
Figure 1 Box-and-whisker plots of sperm DNA fragmentation for different genotypes. The boxes represent the 25
th and 75
th percentiles;
whiskers are lines extending from each end of the box covering the extent of the data on 1.5 × inter-quartile range. The median value is
denoted as the line that bisects the boxes. Circles and asterisks represent the outlier values. Significant differences were measured by multiple
linear regression.
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attenuated the protein-protein interaction of MLH1 and
PMS2.
Discussion
Accumulating evidence demonstrates that MMR plays a
critical role in the maintenance of genetic integrity and
participates in the meiotic recombination process
[14-16]. Although mutations in MMR genes are
considered as potential risk factors for various cancers
[28,29], only limited data exist on the potential role of
polymorphisms in the MMR genes on male infertility.
To our knowledge, this study is the first to provide a
comprehensive evaluation of the relationship between
polymorphisms in MMR and susceptibility to male
infertility in a relatively lar g es a m p l es i z e .O nt h eb a s i s
of analysis of 480 controls and 524 infertility patients
with azoospermia or oligozoospermia, we observed that
Figure 2 FRET imaging of MLH1 and PMS2 interaction in live HEK293T cells. Images of CFP-tagged (green) and YFP-tagged (red)
constructs when transiently expressed in HEK293T cells. Co-localization of co-expressed constructs is shown as yellow in overlay images. The
pseudocoloured images represent FRET signals corrected for any bleed-through using the micro-FRET method (FRETc). A: Co-localization
(overlay) and direct interactions (FRETc) between MLH1-CFP + PMS2 (wt)-YFP were detected in the nucleus. B: Cells co-expressing MLH1-CFP +
PMS2 S775N-YFP showed good co-localization of fluorescent signals but little detectable FRETc signal in the nucleus.
Figure 3 Interaction studies between hMLH1 and hPMS2 variants. A: Western blot of total protein extracts (50 μg each) from HEK293T cells
transfected with pcDNA3.1-MLH1 and either wild-type pcDNA3.1-PMS2 (775Ser) or pcDNA3.1-PMS2 (775Asn) variants. b-actin was used as
controls. B: The lysates of cells co-expressing the two plasmid were immunoprecipitated with anti-MLH1 N-20 antibody, and then detected with
anti-PMS2 (A16-4) antibody. Western blot signals were quantified employing Quantity-One software.
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synonymous SNPs in PMS2 (rs1059060, Ser775Asn) and
MSH5 (rs2075789, Pro29Ser) were associated with
increased susceptibility to poor sperm production.
As an important pathway in the DNA damage repair
network, MMR also plays a critical role in the mainte-
nance of genetic integrity. Thus, it would be expected
that these three significant SNPs that affect sperm DNA
integrity could also modify male infertility risk. Based on
a case-control study consisting of 480 controls and 768
patients with normal sperm count, we found that PMS2
rs1059060 was significantly associated with male inferti-
lity with normal sperm count. Further analysis based on
450 infertile men revealed significant associations of
MLH1 rs4647269 and PMS2 rs1059060 with sperm
DNA fragmentation. However, we did not detect any
association between MSH5 Pro29Ser polymorphisms
and sperm DNA damage. This result is explained by the
fact that MSH5 is a meiosis-specific protein crucial for
reciprocal recombination, and it has no apparent mis-
match repair activity because it is missing the appropri-
ate amino acid residues [30].
MLH1 and PMS2 form the MutLa heterodimer that
leads to the repair of mismatched DNA through activa-
tion of exonuclease-mediated degradation of DNA [31].
Guerrette et al. localized the MLH1-PMS2 interaction
region to amino acids 506-675 of MLH1 and amino
acids 675-850 of PMS2 [32]. It is conceivable that the
PMS2 Ser775Asn polymorphism could directly impact
the integrity of the interaction between MLH1 and
PMS2. In the present study, we provided evidence, for
the first time, that the PMS2 Ser775Asn variant attenu-
ates the interaction of MLH1 and PMS2, as illustrated
by FRET and co-immunoprecipitation assays.
The MSH5 rs2075789 polymorphism in the coding
region of the human MSH5 gene leads to a proline to
serine alteration and is located within the MSH4-MSH5
interacting domain. To address the effect of the Pro29-
Ser alteration on the interaction between MSH4 and
MSH5, a quantitative yeast two-hybrid analysis has been
performed [33]. This alteration causes a moderate but
significant reduction in the interactions between both
proteins, which could affect the formation of the
MSH4-MSH5 heterocomplex. These findings strongly
support our molecular epidemiological observation that
the MSH5 Pro29Ser polymorphism is associated with a
significantly increased risk of azoospermia or oligozoos-
permia. Supporting evidence also comes from associa-
tion studies by other investigators. In a recent study of a
Chinese population with a small sample size, Xu et al.
observed a 2.89-fold increased risk of azoospermia or
oligozoospermia among the MSH5 Pro29Ser allele car-
riers [34]. In addition, a case-control study including 41
women with premature ovarian failure and 39 controls
suggested that there is a correlation between the MSH5
Pro29Ser polymorphism and premature ovarian failure
in women [35].
Another SNP associated with risk in our study
(rs4647269) is intronic. However, SNP rs4647269 tags
SNP rs9852810 (r
2 =1 ,D’ = 1), which was associated
with prostate cancer risk and prostate cancer recurrence
[36]. Because both of these two SNPs are located in the
intron of the MLH1 gene, it is uncertain which one of
these two variants causes increases in male infertility
risk. To identify additional SNPs that could be asso-
ciated with male infertility risk that may be in high link-
age disequilibrium (LD) with these two sites, we
screened all of the common variants (with MAF > 0.05)
within an approximately 20 kb-long region surrounding
these two sites (approximately 10 kb upstream and
approximately 10 kb downstream of these loci) based on
the CHB HapMap data resource. We found that
rs4647269 is in complete LD with SNP rs1046512,
which is located approximately 2.5 kb upstream of start
codon of MLH1. Therefore, it is highly likely that the
rs1046512 SNP near the 5’ region of the MLH1 gene
may be the causal variant.
Another interesting finding was that smoking was
associated with increased risk of male infertility.
Although the effects of tobacco cigarette smoke on male
reproduction are somewhat inconclusive, a number of
studies have shown higher incidences of abnormal
sperm morphology [37,38] and decreased sperm motility
concentration in men who smoke [39,40]. A meta-analy-
sis [41], including 27 studies, indicated that cigarette
smoking is associated with a 13% reduction in sperm
concentration, a 10% reduction of sperm motility, and a
3% reduction of morphologically normal sperm. Further-
more, fluctuation in reproductive hormone levels have
been documented in male smokers [42,43]. However,
the mechanism(s) of these changes, if any, remains
unclear.
Of note, like all case-control studies, selection bias
may exist and might influence interpretation of the
results. However, we believe that potential confounding
bias might have been minimized by matching the con-
t r o l st ot h ec a s e so na g ea n db yf u r t h e ra d j u s t m e n tf o r
the confounding factors in statistical analyses. In addi-
tion, the fact that genotype frequencies of all SNPs in
our controls fit Hardy-Weinberg equilibrium and were
similar to those obtained from the HapMap Project
further supports the randomness of our control selec-
tion. We believe that the selection bias, if any, is unli-
kely to be substantial.
Conclusions
The present study extends the previous understanding
of the MMR polymorphisms and their effects on the
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Page 8 of 10risk of idiopathic azoospermia or oligozoospermia by
further evaluating the contribution of these polymorph-
isms in relation to sperm DNA fragmentation. These
novel findings might be helpful in improving the under-
standing of the role of genetic variation in susceptibility
to reduced sperm DNA integrity and in providing diag-
nostic implications for assisted reproduction success
rates. Although, these three SNPs (rs4647269, rs1059060
and rs2075789) associated with risk in our study are sig-
nificantly higher for some variants in the patient group,
the actual rates are quite low and would potentially
account for a low percentage of infertility. However, it is
important to know that genetic variants associated with
common complex diseases like male infertility are only
“one piece of the puzzle” making up an individual’s
overall risk for disease. It is highly likely that the genetic
risk for developing male infertility is influenced by the
additive effects of many different genetic variants and
other risk factors. So, further research is required to
define their interactions with other susceptibility alleles
and environmental factors can lead to a substantial
increase in male infertility risk, especially when exposed
to certain dietary and lifestyle habits.
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